Combining biomedical data of osteoarthritis patients
The APPROACH project brings together European clinical centers, basic research institutes, small- and medium-sized businesses and pharmaceutical companies. Together, they will combine biomedical data from more than 10 000 people with and without osteoarthritis into a unified bioinformatics platform with the aim of identifying different OA phenotypes. These phenotypes will then be validated in a longitudinal cohort using existing and newly-developed biomarkers. This will allow for the development of guidelines for differentially diagnosing the right patient for the right treatment.
Consortium
1 US & 25 European partners
Budget
€ 17.5 Million
Project period
6.5 years
Start date
1st of June 2015
Latest news
-
APPROACH represented at EULAR 2023 in Milan, Italy
The European Alliance of Associations for Rheumatology (EULAR) held its annual congress in Milan between the 31st of May – 3rd of June. At the congress, APPROACH member Mylene Jansen spoke about gait patterns in knee OA explained by joint structure. -
APPROACH investigators present their research at OARSI 2023
The 2023 edition of the OARSI (Osteoarthritis Research Society International) world congress was organised on March 17th - 20th, in Denver, Colorado, the USA. The topic for this year’s congress was “Challenges ahead in osteoarthritis research”. -
APPROACH final project report available
The APPROACH consortium publishes a final project report reflecting on its scientific and technical results, the potential impact and exploitation of these results, as well as the lessons learned and further opportunities for research in the field of osteoarthritis.
@APPROACH_EU